Home Health Care News October 26, 2024
UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) leaders are reportedly expected to meet with officials from the Department of Justice over the next week to discuss their pending deal. The companies will likely make a final case for why the deal should go through, while the DOJ considers whether to officially file a lawsuit to block it.
Bloomberg first reported on the meeting, which could commence as early as Monday, according to sources “familiar with the matter.”
UnitedHealth Group agreed to acquire Amedisys in June of 2023 for $3.3 billion. Since then, they have been waiting for approval from the DOJ, which has requested further information on the deal and began considering a lawsuit early this year.
Today's Sponsors
Today's Sponsor